Company Overview
| Stock Name | Sinolife Utd |
|---|---|
| Stock Code | 03332 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 我們是一家快速成長的營養膳食補充劑零售商,製造並透過中國一二線城市的自營零售店銷售兩個主要品牌中生及康培爾旗下的優質及安全的營養膳食補充劑。於2013年6月30日,在中國一線及二線城市合共經營49家自營零售店。 |
| Listing Date | 2014-01-15 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國江蘇省南京玄武區長江路188號德基大廈30樓 |
| Business Address (Hong Kong) | 香港康樂廣場1號怡和大廈40樓 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | zs-united.com |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 2.00 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | RMB 0.1 / shares |
| Offer Period | 2014-01-08 to 2014-01-08 |
| Global Offering Shares | 203,800,000 shares |
| HK Public Offer Shares (Initial) | 20,380,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 183,420,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 814,911,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 2.7% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 407,600,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 177.6M |
| Est. Threshold | HK$ 9.71B |
| Analysis Result | HK market cap below threshold, need +5369% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣57.2百萬元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2010 | 2011 | 2012 | 2013-06 |
|---|---|---|---|---|
| Revenue | 66,850 | 103,244 | 150,372 | 85,965 |
| Cost of sales | -13,588 | -20,080 | -20,276 | -11,264 |
| Gross profit | 53,262 | 83,164 | 130,096 | 74,701 |
| Other income and gains, net | 679 | 337 | 1,484 | 581 |
| Selling and distribution expenses | -18,732 | -20,339 | -34,047 | -22,216 |
| Administrative expenses | -14,214 | -15,955 | -20,621 | -12,788 |
| Profit before tax | 20,995 | 47,207 | 76,912 | 40,278 |
| Income tax expense | -5,207 | -12,393 | -19,675 | -10,578 |
| Profit for the year | 15,788 | 34,814 | 57,237 | 29,700 |
| Profit attributable to owners | 15,788 | 34,814 | 57,237 | 29,700 |
Balance Sheet
| Item | 2010 | 2011 | 2012 | 2013-06 |
|---|---|---|---|---|
| Cash and cash equivalents | 36,306 | 62,775 | 93,220 | 128,383 |
| Trade and bills receivables | 3,446 | 5,989 | 3,731 | 4,188 |
| Inventories | 5,438 | 10,944 | 13,684 | 9,962 |
| Total current assets | 45,970 | 89,558 | 111,427 | 164,634 |
| Total assets | 71,007 | 113,896 | 139,631 | 193,128 |
| Total current liabilities | 10,520 | 18,703 | 20,118 | 20,327 |
| Total liabilities | 10,520 | 18,703 | 20,118 | 20,327 |
| Total equity | 60,487 | 95,193 | 119,513 | 172,801 |
| Equity attributable to owners | 60,487 | 95,193 | 119,513 | 172,801 |
Cash Flow Statement
| Item | 2010 | 2011 | 2012 | 2013-06 |
|---|---|---|---|---|
| Net cash from operating activities | 17,347 | 35,181 | 57,923 | 35,396 |
| Net cash from investing activities | -124 | -8,835 | 4,670 | -23,937 |
| Net cash from financing activities | -12,836 | 340 | -32,307 | 24,486 |
| Net increase in cash | 4,387 | 26,686 | 30,286 | 35,945 |
| Depreciation of PP&E | 2,203 | 2,091 | 1,982 | 1,389 |
| Amortisation of intangible assets | 65 | 65 | 65 | 33 |
| Purchase of PP&E | -550 | -246 | -2,390 | -2,364 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 2.66 |
|---|---|
| First Day Open | HK$ 2.78 |
| First Day Change | 33.00% |
| First Day Volume | 179746000.0 |
| First Day Turnover | 492908000.0 |
| Use of Proceeds | 1、約43%(或143.6百萬港元)將用于擴張我們位于江蘇省南京市的生產設施,其中:
a 約31%(或103.6百萬港元)將用于建設一條新生產線,以制造軟膠囊劑、罐裝粉劑及迷你瓶裝飲料形式的產品,設計年產能分別為800,000劑、650,000劑及2,000,000劑;
b 約6%(或20.0百萬港元)將用于建設一個研發測試中心;及
c 約6%(或20.0百萬港元)將用于設立一個信息及物流控制中心;
2、約34%(或113.5百萬港元)將于未來兩年內用于為我們的營銷及推廣活動提供資金,借以提高中生及康培爾品牌在全國范圍內的品牌知名度,其中:
a 約23%(或76.8百萬港元)將用于電視、印刷品、電臺及網上廣告;
b 約6%(或20.0百萬港元)將用于聘請明星代言人;
c 約3%(或10.0百萬港元)將用于通過創作及推出新企業宣傳片、新產品包裝設計及新營銷材料以推廣及提升我們的企業及品牌形象;
d 約2%(或6.7百萬港元)將用于在主要節假日于中國各地舉行的推廣活動;
3、 約18%(或68.5百萬港元)將用于在未來數年內加強及擴張我們的現有銷售網絡,并滲透至新區域,尤其是中國一線城市、省會及富裕的二線城市,其中:
a 約6%(或22.8百萬港元)將用于支持我們2014年的銷售網絡擴張。根據當前的市況,我們現擬在2014年年底前分別將中生零售店數目及康培爾零售店數目增加至45家及72家;
b 約12%(或45.7百萬港元)將用于支持我們2015年及2016年的銷售網絡擴張。視乎當時的宏觀經濟環境及我們產品的市場需求,按開設中生零售店及康培爾零售店的最低資金需求計算,所得款項將足以讓我們在2015年及2016年分別再開設20家及80家中生零售店及康培爾零售店;
4、余下約5%(或19百萬港元)將用作我們的營運資金及其他一般企業用途。 |
Underwriting Syndicate
Sole Sponsor (1)
BOCOM International (Asia) Limited CE API271
Overall Coordinators (1)
交银国际证券有限公司 CE APJ121
Joint Bookrunners (1)
交银国际证券有限公司 CE APJ121
Joint Lead Managers (1)
交银国际证券有限公司 CE APJ121
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 康健企业咨询及投资有限公司 | 44,304,000 HKD | — | 2.70% | — | 6 months | 2014-07-15 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 桂平湖 | — |
| Company Secretary | 支卉、甘美霞 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 桂先生持有內資股476,685,000股,佔全球發售後本公司股本總額約58.50%;其配偶吳女士持有52,965,000股,佔約6.50%;上海復星持有61,111,000股,佔約7.50%。 |
|---|




